3. Skin Protection
Most in vitro studies on skin protection study the ability of
Aloe vera and active compounds in wound healing. The immortalized human keratinocyte HaCaT cell line, the primary normal human epidermal keratinocytes HEKa cell line, and fibroblasts cell lines are the most used. These studies have revealed that
Aloe vera and its major compounds (aloesin, aloin, and emodin) exert their protective action mainly through antioxidant and anti-inflammatory mechanisms. Hence,
Aloe vera up-regulated TFGβ1, bFGF, and Vegf-A expression in fibroblasts and increased keratinocyte proliferation and differentiation by lysosomal membrane stability
[28][29][30][31][32][28,29,30,31,32]. Moreover,
Aloe vera solution could accelerate corneal wound closure at low concentrations (≤175 μg/mL) by increasing type IV collagen-degrading activity in a cellular model of primary cultures of corneal epithelial cells
[33]. Furthermore, aloin exerted skin protection by reducing IL-8 production, DNA damage, lipid peroxidation, and ROS generation and by increasing GSH content and SOD activity
[34]. The compound aloesin resulted in promoting wound healing by increasing cell migration via phosphorylation of Cdc42 and Rak1, cytokines, and growth factors
[35]. In addition to this healing activity, it has been seen that
Aloe polysaccharide (20, 40, and 80 µg/mL for 24 h) could be a beneficial agent in psoriasis as evidenced in the inhibition of TNF-α levels and IL-8 and IL-12 protein expression in human keratinocyte HaCaT cell line.
As for in vivo studies, the most common models are genetically modified animals (BALB/c mice, HR-1 hairless mice and SKH-1 hairless mice) and UV and X-ray skin damage in animals. Most of these in vivo studies have been done with
Aloe vera extracts and gel. Application of topical
Aloe vera favored wound healing in animal models with dermal incisions by reducing inflammatory cell infiltration, increasing CD4+/CD8+ ratio lymphocytes, and improving epidermal thickness and collagen deposition
[36][37][38][39][36,37,38,39]. In another study conducted in Indonesia with several medicinal plants, the effect of
Nigella sativa oil gel and
Aloe vera gel to treat diabetic ulcers was investigated.
Aloe vera resulted to be more efficient in improving wound healing on alloxan-induced diabetes in Wistar rats with wounds on dorsum as evidenced by a decrease of necrotic tissue and inflammation and an improvement of re-epithelialization
[40]. Furthermore, a UV-induced mice model revealed that
Aloe vera gel powder increased epidermal growth factor and hyaluronan synthase and reduced matrix metalloproteinases expression (types 2, 9, and 13)
[41][42][41,42].
Aloe sterols are involved in this UV protection
[43]. Likewise, it has been observed that
Aloe vera protected against X-radiation through antioxidant mechanisms (increased antioxidant enzyme activity and GSH content and reduced ROS production and lipid peroxidation)
[44][45][44,45]. Among isolated compounds, investigations with the compounds aloe-emodin and aloesin have shown that their healing activity is due to angiogenic properties
[46][47][46,47].
In the last 6 years, several clinical trials have also been carried out. Some of these have been aimed at evaluating the effectiveness of
Aloe vera on ulcers. Hence, the administration of
Aloe vera gel twice daily for 3 months improved and accelerated wound healing as well as reduced hospitalization time
[48][49][48,49]. Moreover, in a randomized, triple-blind clinical trial with 80 patients hospitalized in the orthopedic ward, Hekmatpou et al.
[50] demonstrated that
Aloe vera gel twice daily for 10 days prevented the development of pressure ulcers on the areas of hip, sacrum, and heel. Moreover, clinical trials have demonstrated that
Aloe vera facilitated rapid tissue epithelialization and granulation in burns
[51], promoted healing of cesarean wound
[52], and accelerated wound healing of split-thickness skin graft donor sites
[53]. Furthermore,
Aloe vera has been investigated in randomized, double-blind, placebo-controlled studies for its benefits to maintain healthy skin. Therefore, the daily oral intake of 40 µg of
Aloe sterol (cycloartenol and lophenol) for at least 12 weeks improved skin elasticity in men under 46 years exposed to the sunlight but do not use sunscreen to protect themselves
[54], reduced facial wrinkles in Japanese women over 40 years old by stimulating hyaluronic acid and collagen production
[55], and increased gross elasticity, net elasticity, and biological elasticity in women aged 30–59
[56]. However, despite clinical evidence on the protective role of
Aloe vera in the skin, there are clinical trials that have not yet found effectiveness of this medicinal plant, particularly in decreasing radiation-induced skin injury. Two clinical trials have been published between 2014 and 2019 in relation to this effect. Both studies found that topical administration of
Aloe vera as gel or cream did not reduce the prevalence and severity of radiotherapy-induced dermatitis and skin toxicity in breast cancer patients compared to control group
[57][58][57,58].
4. Anti-Inflammatory Activity
Most recent studies on anti-inflammatory activity of
Aloe vera are focused on the action mechanism of isolated compounds in murine macrophage RAW264.7 cells and mice stimulated with LPS. Hence, the potential anti-inflammatory effect of aloin is related to its ability to inhibit cytokines, ROS production, and JAK1-STAT1/3 signaling pathway
[59][60][59,60]. Moreover, aloe-emodin sulfates/glucuronides (0.5 μM), rhein sulfates/glucuronides (1.0 μM), aloe-emodin (0.1 μM), and rhein (0.3 μM) inhibited pro-inflammatory cytokines and nitric oxide production, iNOS expression, and MAPKs phosphorylation
[61].
In another study, Thunyakitpisal et al.
[62] demonstrated that acemannan increased IL-6 and IL-8 expression and NF-κB/DNA binding in human gingival fibroblast via a toll-like receptor signaling pathway. Since there is a relation between high IL-1β levels and periodontal diseases, Na et al.
[63] investigated the anti-inflammatory properties of aloin in human oral KB epithelial cells stimulated with saliva from healthy volunteers. This study revealed that those saliva samples with high content in IL-1β stimulated IL-8 production in KB cells, and pretreatments with aloin inhibited IL-8 production by decreasing p38 and extracellular signal-regulated kinases pathway.
In addition to isolated compounds, Ahluwalia et al.
[64] evaluated the activity of AVH200
®, a standardized
Aloe vera extract which contains alin and acemannan on the activation, proliferation, and cytokine secretion of human blood T cells obtained from healthy individuals aged 18–60, and they found that it decreased CD25 and CD3 expression on CD3(+) T cells. Moreover, AVH200
® exhibited concentration-dependent T cell proliferation suppression and IL-2, IFN-γ, and IL-17A reduction. Moreover, the anti-inflammatory effect of
Aloe vera has also been investigated in an acetaminophen-induced hepatitis (inflammatory condition of the liver) mice model. The results of this study revealed that
Aloe vera (150 mg/kg) reduced hepatic MDA, IL-12, and IL-18 levels and ALT and increased GSH content
[65].
5. Anticancer Effects
Studies conducted in the years of the re
view of this
earch work focusing on cancer are mostly in vitro and in vivo studies. In vitro studies have the main purpose of identifying potential molecules with cytotoxic activity for later evaluation in in vivo studies and clinical trials. In addition, in vitro studies allow elucidating the mechanism of action by identifying promising pharmacological targets. In vivo studies allow us to understand the pharmacological activity and behavior in living organisms prior to their study in humans. Since clinical trials are very limited, and as it is not possible to confirm the anti-cancer activity of
Aloe vera and its bioactive principles, it would be interesting for future research to focus on this activity based on the promising in vitro and in vivo results.
In vitro and in vivo studies included
in th
ere e present review are aimed at evaluating cytotoxic and antitumor activity against a variety of cancer types using a diversity of cell lines and animal models (breast and gynecological cancers such as cervical cancer and ovarian cancer, malignant conditions of the gastrointestinal tract (i.e., oral cavity, esophagus, colon) and accessory digestive organs (pancreas), osteosarcomas, and melanoma). One clinical trial focused on the efficacy of
Aloe vera on ocular surface squamous neoplasia; this clinical trial has been included at the end of this section.
MCF-7 cells, which express estrogen receptor, are the most popular breast cancer cell line, and the immortal HeLa cell line are the oldest and most used cervical cancer cells
[66][67][66,67].
Aloe vera crude extracts (40%, 50%, and 60% for 6, 24, and 48 h) reduced cell viability of cancer cell lines (human breast MCF-7 and cervical HeLa) through apoptosis induction (chromatin condensation and fragmentation and apoptotic bodies appearance in sub-G0/G1 phases) and modulation of effector genes expression (an increase in cyclin D1, CYP1A1, and CYP1A2 expression and a decrease in p21 and bax expression)
[68]. Moreover, the isolated compound aloe-emodin has resulted to be an effective anticancer agent against both MCF-7 cells and HeLa cells by inducing mitochondrial and endoplasmic reticulum apoptosis and inhibiting metastasis oxidative stress
[69][70][71][72][69,70,71,72]. Furthermore, a recent study demonstrated that
Aloe vera extract (300 mg/kg) and training (swimming) combined exerted a protective anticancer effect in mice with breast cancer by inhibiting the COX pathway (COX-2 reduction levels) and prostaglandin E2 production
[73]. Finally, aloesin reduced tumor growth in in vitro and in vivo models of ovarian cancers by inhibiting the MAPK signaling pathway
[74].
For malignant conditions of gastrointestinal tract and accessory digestive organs, emodin (10, 20, 30, 40 μM for 24 and 48 h) decreased cell proliferation and Bcl-2 protein levels and increased caspase-3 protein expression and Bax protein levels in human oral mucosa carcinoma KB cells
[75]. Moreover, aloe-emodin has been shown to effectively suppress esophageal TE1 cancer cells in a concentration-dependent manner (from 2.5 µM to 20 µM concentrations assayed) through inhibiting AKT and ERK phosphorylation and reducing the number of cells in the S phase
[76]. Furthermore,
Aloe polysaccharide induced autophagy alone and in combination with radiation in pancreatic carcinoma BxPC-3 cells as evidenced in ULK1 mRNA expression upregulation and BECN1 and BCL-2 mRNA expression downregulation
[77]. Finally, several in vitro and in vivo studies were performed to evaluate the potential anticancer properties of
Aloe vera and its isolated compounds in colon cancer (fourth most common cancer and the third leading death cause)
[78]. Chen et al.
[79] exhibited cytotoxic properties of aloe-emodin on colon cancer cells at 10, 20, and 40 μM concentrations through activating the apoptotic pathway, increasing ROS production, and cytosolic calcium levels and up-regulating ER stress-related proteins. Moreover,
Aloe vera powder and extract 1% and 3% protected C57BL/6J mice from aberrant crypt foci colorectal cancer by increasing hepatic phase II enzyme glutathione S-transferase mRNA levels
[80]. Furthermore,
Aloe vera gel (200 or 400 mg/kg/day orally) reduced inducible NO synthase and COX2 expression, NF-kB activation, and cell cycle progression, inducing cellular factors in BALB/c female mice with induced colitis-associated colon carcinogenesis.
Osteosarcomas are uncommon bone tumors in which malignant cells produce osteoid
[81]. Aloe-emodin has also resulted to be a promising photosensitive agent against the human osteosarcoma MG-63 cell line via ROS/JNK signaling pathway as evidenced in an increase of caspases, cytochrome c, CHOP, and GRP78 expression
[82][83][82,83].
For melanoma (malignant transformation of melanocytes), aloe-emodin protected against metastatic human melanoma cells by decreasing cell proliferation, increasing cell differentiation, and transamidating activity of transglutaminase and dabrafenib antiproliferative activity
[84][85][84,85].
Regarding clinical trials conducted in recent years on anticancer activity, Damani et al.
[86] reported the efficacy of
Aloe vera eye drops 3 times daily for 3 months in the regression of ocular surface squamous neoplasia in a 64-year-old Hispanic woman. On the other hand, Koo et al.
[87] stated that aloe polysaccharide could reduce tobacco associated diseases such as cancer due to its ability to increase urinary excretion of benzo(a)pyrene and cotinine.
6. Antidiabetic Effect
Diabetes is a chronic disease presenting with high levels of glucose in blood because of an insulin resistance or an insulin deficiency. Studies on the effect of
Aloe vera in diabetes and related complications have been investigated mainly in animal models induced by streptozotocin. Consistent evidence supports that oxidative stress is a main cause of the beginning and the progression of diabetes complications such as nephropathies and neuropathies. Hence, using this experimental model,
Aloe vera showed to reduce blood glucose levels, to increase insulin levels, and to improve pancreatic islets (number, volume, area, and diameter)
[88], and this medicinal plant protected from oxidative stress-induced diabetic nephropathy and anxiety/depression-like behaviors
[89]. Moreover,
Aloe vera topical administration (60 mg/mL, four times daily for 3 days of eye drops) favored corneal re-epithelialization in streptozotocin-induced diabetic Wistar rats with corneal alkali burn injury
[90]. Furthermore, experiments with genetically modified animals have revealed that
Aloe vera polysaccharides (100 µg/g for 3 weeks) are responsible for the decrease of blood glucose levels
[91]. A recent in vitro study showed that the action mechanism of
Aloe vera polysaccharides antidiabetic effect is related to its ability to inhibit apoptosis and endoplasmic reticulum stress signaling
[91]. In another in vitro study using a high-glucose-induced toxicity cell model, the compound aloe-emodin (20 μM) protected RIN-5F cells derived from rat pancreatic β-cells from glucotoxicity through an apoptotic and anti-inflammatory effects
[92]. Lastly, the intake of
Aloe vera (300 mg twice day for 4 weeks) decreased fasting blood glucose in pre-diabetic subjects
[93].
7. Antioxidant Properties
Antioxidants are compounds that prevent or slow down biomolecule oxidative damage caused by ROS through free radical scavenging, metal chelation, and enzyme regulation
[94]. Kumar et al. 2017
[95] investigated the potential antioxidant activity of crude methanolic extracts of
Aloe vera from six agro-climatic zones of India using different in vitro methods (i.e., DPPH, metal chelating, and reducing power assay). Antioxidant activity was higher in those species collected in Northern India than in Southern India, which is related to a high content in alkaloids, glycosides, phenolic compounds, flavonoids, and saponin glycosides. Moreover,
Aloe vera ethanol extract protected, particularly human microvascular endothelial cells, against hydrogen peroxide and 4-hydroxynonenal-induced toxicity by reducing ROS production and HNE-protein adducts formation
[96]. The antioxidant activity of
Aloe vera is, at least in part, due to anthraquinones and related compounds (10 µM) which possess peroxyl radical scavenging activity and reducing capacity
[97].
Apart from these in vitro assays, in a clinical trial with 53 healthy volunteers, the intake of
Aloe vera gel extract (14 days) increased total antioxidant capacity of plasma of subjects
[98].
8. Bone Protection
In vitro studies with isolated
Aloe vera compounds have been aimed at studying the potential protective effect on bone pathogenesis. Aloe-emodin induced chondrogenic differentiation on clonal mouse chondrogenic ATDC5 cells which is related to bone formation through BMP-2 and MAPK-signaling pathway activation
[99]. Moreover, aloin has resulted to be beneficial in osteoporosis and osteopenia disorders by suppressing receptor activator of NFĸB ligand (RankL) induced through NF-κB inhibition in mouse macrophage RAW 264.7 cells
[100][101][100,101].
9. Cardioprotective Effect
In vivo models of ischemia-reperfusion injury are commonly employed to evaluate the cardioprotective activity of
Aloe vera.
Aloe vera administered with gastric gavage previous to abdominal aorta and spinal cord ischemia increased antioxidant enzymes activity (SOD, CAT, and GPx) and reduced lipid peroxidation level (MDA content), edema, hemorrhage, and inflammatory cell migration in Wistar albino rats
[102][103][102,103]. Moreover, barbaloin, also known as aloin, (20 mg/kg/day, 5 days) administered intragastrically reduced myocardial oxidative stress and inflammatory response and increased AMPK signaling in Sprague-Dawley rats in a myocardial ischemia/reperfusion injury
[104]. Esmat et al.
[105] demonstrated that this compound (50 mg/kg body weight, twice weekly over 2 weeks), administered intramuscularly, had non-atherogenic activity and iron chelating properties. Another compound isolated from
Aloe vera and investigated for its cardioprotective properties is aloe-emodin. In an in vitro model of heme protein (hemoglobin), it was demonstrated that aloe-emodin (100 μM) had its maximum activity as an anti-aggregatory agent as evidenced in structural alterations of β sheet and the appearance of α helices
[106]. On the other hand, an in vivo study revealed that aloe-emodin could alleviate hyperlipidemia by reducing total cholesterol and low-density lipoprotein-cholesterol levels at doses of 50 and 100 mg/kg for 6 weeks in male Wistar rats
[107]. Regarding clinical studies, a double-blind randomized controlled trial showed that
Aloe vera 300 mg and 500 mg/twice day for 4 and 8 weeks reduced HbA1C, total cholesterol, LDL, and triglyceride levels in pre-diabetic patients
[92]. Furthermore, the oral gavage administration of
Aloe vera (30 mg/kg/day for 1 month) resulted to decrease ischemic fiber degeneration by preventing the formation of lipid peroxides, increasing antioxidant enzymes, and up-regulating the transcription factor NRF1 in Wistar albino rats
[108].
10. Antimicrobial and Prebiotic Activity
Different studies have been carried out to evaluate the antimicrobial activity of
Aloe vera and its main constituents. Most of these studies are in vitro and focus on the antibacterial activity. One of the most studied bacteria are
Staphlococcus aureus and
Pseudomonas aeruginosa. Hence,
Aloe vera aqueous extract reduced growth and biofilm formation against methicillin resistant
Staphylococcus aureus [109]. Moreover, this bacteria has also been inhibited by
Aloe vera gel (50% and 100% concentrations), along with other oral pathogens obtained from patients with periapical and periodontal abscess including
Actinobacillus actinomycetemcomitans,
Clostridium bacilli, and
Streptococcus mutans using disc diffusion, micro-dilution, and agar dilution methods
[110]. One of the compounds attributed to antibacterial activity against
Staphylococcus aureus is aloe-emodin which acts by inhibiting biofilm development and extracellular protein production
[111]. In the case of
Pseudomonas aeruginosa,
Aloe vera extracts have shown to inhibit the growth of multidrug-resistant
Pseudomonas aeruginosa isolated from burned patients with wounds infections at MIC
50 and MIC
90 values of 200 µg/mL
[112].
Pseudomonas aeruginosa growth and biofilm formation inhibition has been also demonstrated for
Aloe vera inner gel. This
Aloe vera inner gel also inhibited other Gram-negative bacteria (
Helicobacter pylori and
Escherichia coli) as well as the fungus
Candida albicans [113]. Moreover, in another study,
Aloe vera hydroalcoholic extract showed antibacterial activity against
Enterococcus faecalis, an infecting microorganism of the root canals of teeth, with inhibition zones of 13 mm (saturated) and 9.6 mm (diluted)
[114]. Furthermore, concentrations up to 1 mg/mL of
Aloe vera aqueous extracts could inhibit
Mycobacterium tuberculosis growth, which is the pathogen responsible for causing tuberculosis, one of the most lethal infectious diseases worldwide
[115]. Finally, in a clinical trial with 53 healthy volunteers, the daily drinking of
Aloe vera gel extract for 14 days exerted an antimicrobial activity as shown in a reduction of
Lactobacillus spp. number
[98].
Antiviral activity of
Aloe vera has been investigated for herpes simplex virus type 1 and H1N1 subtype influenza virus.
Aloe vera extract gel (concentrations from 0.2% to 5%) showed antiviral activity against herpes simplex virus type 1 on Vero cells by inhibiting its growth
[116]. On the other hand, in vitro studies have demonstrated that
Aloe polysaccharides decreased H1N1 subtype influenza virus replication and viral adsorption period by interacting with influenza virus particles. Moreover, in vivo studies with SPF BALB/c mice infected with PR8(H1N1) improved clinical symptoms and lung damage
[117].
Finally, there are other studies which support the prebiotic potential of
Aloe vera defined as “a substrate that is selectively utilized by host microorganisms conferring a health benefit”.
Aloe vera mucilage (rich in acemannan) could improve gastrointestinal health by increasing short chain fatty acids and modifying bacterial composition
[118][119]. Moreover, acemannan and fructans from
Aloe vera increased bacterial growth, especially
Bifidobacterium spp. population
[119][120].
11. Other Effects
Aloe vera has also been investigated for treating reproductive health care problems. The results of these works carried out with experimental animals are contradictory. While Asgharzade et al.
[120][121] demonstrated that
Aloe vera ethanol extract (150 and 300 mg/kg) had negative effects on spermatogenesis and sperm quality in Wistar rats, Erhabor and Idu
[121][122] observed that
Aloe vera ethanol extract (400 mg/kg) improved male sexual behavior (mount frequency and latency, intromission frequency and latency, and testosterone levels) and Behmanesh et al.
[122][123] that
Aloe vera extract increased body and testis weights, spermatocyte and spermatids quantity, and seminiferous tubule diameter and height.
Aloe vera processed gel prevented of ovoalbumin-induced food allergy by exerting an anti-inflammatory action (histamine, mast cell protease-1, and IgE reduction)
[123][124].
At the blood level, the oral administration of
Aloe vera gel prevented and restored lymphopenia and erythropenia as well as IgA secretion on cyclophosphamide-induced genetically modified mice
[124][125]. Moreover,
Aloe vera ethanol extract (200 mg/kg, 400 mg/kg, and 600 mg/kg) normalized levels of white blood cells, red blood cells, and platelet count through antioxidant mechanisms
[125][126].
Regarding diseases of the musculoskeletal system, aloe-emodin showed to reduce viable cell numbers (concentrations ≥10 µM) and to induce apoptosis by arresting G2/M phase (concentrations ≥20 µM) in MH7A human synovial fibroblast-like cells, aloe-emodin being a promising agent to treat rheumatoid arthritis and a complementary treatment to methotrexate
[126][127]. Moreover,
Aloe vera lyophilized extract ointment reduced tendon lesions and increased non-collagenous proteins in Wistar rats with partial transection of the calcaneal tendon
[127][128].
The dose of 10 mg/kg of
Aloe vera aqueous extract (3 times daily for a week) resulted to be the most effective in morphine withdrawal syndrome in morphine-dependent female rats as shown in agitation, disparity, and floppy eyelids reduction
[128][129].
Finally, highlighting the protective effect of
Aloe vera gel extract (seven weeks, 500 mg/kg b.w. daily) on pulmonary tissue of cigarette smoke induced in Balb/c mice by reducing mucin production, citrulline and NO levels, and peroxidative damage
[129][130].